Tag: Macular Degeneration

Lesions from soft drusen/pigment epithelial detachments have lower mean quantitative autofluorescence, while those from subretinal drusenoid deposits have higher

Higher dietary nitrate intake linked to reduced risk for progression to late age-related macular degeneration

At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab

Presence of HRVD can be identified in model including SDD, high-density lipoprotein with accuracy of 78.5 percent

Use of lipid-lowering drugs, antidiabetic drugs associated with lower prevalence of any age-related macular degeneration

1.49 million people aged 40 years and older are living with late-stage AMD in the United States

Odds of being lost to follow-up greater among very old patients, Black and Hispanic patients, and Medicaid patients

Distinct serum and genetic risks, associated systemic diseases seen with soft drusen, subretinal drusenoid deposits

Model compares costs for ranibizumab port delivery system versus conventional intravitreal antivascular endothelial growth factor injections

No increased risk for lung cancer, reduced risk for progression to late AMD seen with lutein/zeaxanthin as replacement for beta-carotene